Showing results for: Pharmaceutical Systems
Johns Hopkins University’s Bloomberg School of Public Health presents a podcast with evidence and experts to help listeners understand today’s public health news. Start listening to the podcast below: Episode 316 – Nepal’s Growing COVID-19 Crisis Nepal is suffering from a growing humanitarian crisis. Less than 4% of the country is vaccinated, test positivity rates [more…]
Read More...
The World Trade Organization’s agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has established common minimum standards of patent protection across the globe. Countries had different transition periods to adapt to international rules according to their level of development. Least Developed Countries (LDCs) had an extended period to start applying TRIPS and patent protection [more…]
Read More...
The PharmacoVigilance Monitoring System (PViMS) is a web-based application used by clinicians, regulatory bodies, and implementing partners to monitor the safety of medicines. PViMS enables the implementation of active surveillance activities in LMICs by addressing the entire data collection, data analysis, and reporting process. This allows decision makers to identify potential adverse events related to [more…]
Read More...
The need for strong pharmaceutical systems and supply chains has never been so clear, nor so urgent. MSH, in partnership with Deloitte, hosted the webinar ‘Seizing the moment: Providing faster access to quality medical products during COVID-19 and beyond.’ Experts in health supply chain management, pharmaceutical services, and health technologies discussed novel approaches emerging from [more…]
Read More...
GMS Procurement and Supply Management tools and templates support Principal Recipients (PRs) in their management of medications and health supplies. The tools assist PRs to ensure proper forecasting, procurement, stock management, and distribution within Global Fund grants.
Read More...
COVID-19 has triggered an urgent need for new medical products, including vaccines, medicines, diagnostics, personal protective equipment (PPE), and other medical devices such as those that deliver oxygen. As researchers rush to develop these products and clinicians plan for their delivery and safe use, national regulatory authorities play an essential public health role in ensuring [more…]
Read More...
In the course of almost 10 years of operation, GMS progressively refined its approach to organizing and implementing short-term technical supported, and has consequently identified the ingredients or best practices it considers to be essential to producing high-quality short-term technical support for grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). [more…]
Read More...
Gender disparities vary across health systems and affect access to and use of pharmaceutical products and services. This checklist guides pharmaceutical systems program managers and implementers to assess how gender relates to program goals and objectives. The checklist is intended to catalyze discussion on how to apply strategic, intentional, and resourced technical support for gender [more…]
Read More...
By 2030, more people in sub-Saharan Africa will be affected by diseases associated with wealth than those associated with poverty. How can we adapt and design our programs to address this imminent need? In multiple countries, MSH is leveraging infectious disease platforms to address the growing burden of NCDs. This webinar highlights experience integrating services [more…]
Read More...
This webinar, hosted by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program addresses how access to and use of quality data and information management tools enables governments, healthcare providers, and program managers in low- and middle-income countries (LMICs) to make effective and data-informed decisions. This webinar provides an overview of how [more…]
Read More...